Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Disney's Jettisoned LGBTQ Animated Film 'Nimona' Acquired By Netflix

Netflix (NASDAQ: NFLX) has acquired the rights to the unfinished animated film adaptation of ND Stevenson’s best-selling graphic novel “Nimona” which was canceled by the Walt Disney Co. (NYSE:

Benzinga

Repare Therapeutics Shares Dip After Updated RP-3500 Data In Solid Tumors

Repare Therapeutics Inc (NASDAQ:RPTX) presented updated data from its ongoing Phase 1/2 TRESR trial of RP-3500 for solid tumors with specific synthetic-lethal genomic alterations. The data were featured at the AACR Annual Meeting included monotherapy Phase 1 (Module 1) results from 120 patients. RP-3500 monotherapy appeared to be safe and well-tolerated. Mild to…

Benzinga

Here's Why OrganiGram Shares Are Rising

OrganiGram Holdings Inc (NASDAQ: OGI) shares are trading higher by 8.72% at $1.62 during Tuesday's pre-market session after the company reported better-than-expected second-quarter sales results and said it expects third-quarter sales to be higher than second-quarter 2022.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Lixte Biotech Shares Jumps Over 100% On Promising Preclinical Data From Lead Program In KRAS-Mutant Cancers

LIXTE Biotechnology Holdings Inc (NASDAQ:LIXT) shares are trading higher after the presentation of new data from drug combinations of LIXTE's lead clinical cancer compound, LB-100. Data were shared at the Annual Meeting of the American Association for Cancer Research (AACR). LIXTE's lead clinical compound and protein phosphatase 2A (PP2A) inhibitor, LB-100, further activates…

Benzinga

Benzinga's Daily Brief On Trending Tickers For April 12, 2022: Veru, Kohl's Corporation, BioCardia, And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the

Benzinga

The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Here's Why Ocugen Shares Are Falling

Ocugen Inc (NASDAQ: OCGN) shares are trading lower by 5.86% to $2.73 during Tuesday's pre-market session after the company announced that it was informed by the FDA that the agency placed its Phase 2/3 immuno-bridging and broadening study for COVAXIN, OCU-002, on clinical hold.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

OrganiGram Holdings: Q2 Earnings Insights

OrganiGram Holdings (NASDAQ:OGI) reported its Q2 earnings results on Tuesday, April 12, 2022 at 07:02 AM. Here's what investors need to know about the announcement.

Benzinga

Analyst Ratings for Alnylam Pharmaceuticals

Alnylam Pharmaceuticals (NASDAQ:ALNY) has observed the following analyst ratings within the last quarter:

Benzinga

Expert Ratings for CrowdStrike Holdings

Within the last quarter, CrowdStrike Holdings (NASDAQ:CRWD) has observed the following analyst ratings:

Benzinga

Analyst Ratings for Atlantica Sustainable

Analysts have provided the following ratings for Atlantica Sustainable (NASDAQ:AY) within the last quarter:

Benzinga

Hyzon Motors Appoints Samuel Chong As Finance Head

Hyzon Motors Inc (NASDAQ:HYZN) has appointed Samuel Chong as its Chief Financial Officer, effective April 12, 2022. Chong will succeed Mark Gordon, who has served as Hyzon's CFO since August 2020. Chong has served as the Treasurer and Head of Investor Relations at Fluence Energy Inc (NASDAQ:FLNC) and as Treasurer of Gogo Inc (NASDAQ:GOGO). He holds…

Benzinga

Why This Nvidia, Qualcomm Analyst Is Lowering Price Targets For These Chip Stocks

Nvidia Corporation (NASDAQ: NVDA) shares command a premium valuation, and sell-side's theses have all along justified its valuation due to the chipmaker's strong growth profile and optionality.

Benzinga

Tilray Determined To Resolve Hexo's Debt, Signs Definitive Agreement On Heels Of Earnings

Tilray Brands, Inc. (NASDAQ: TLRY) confirmed Tuesday it has signed a definitive agreement for a commercial and financial partnership with HEXO Corp. (NASDAQ: HEXO).

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Nanobiotix's Radiotherapy Combo Therapy Shows Boosted Anti-Tumor Activity In Preclinical Studies

Nanobiotix SA (NASDAQ: NBTX)

Benzinga

Morning Brief: Top Stories Dominating Financial Media on Tuesday, April 12

CNBC Entrepreneur Behind Microsoft’s Wunderlist Raised $11M - Read Why

Benzinga

A Peek Into The Markets: US Stock Futures Down Ahead Of March Inflation Report

Pre-open movers U.S. stock futures traded lower in early premarket trade after the Nasdaq Composite index closed at 13,411.96, a dip of almost 300 points. Investors are awaiting the annual inflation number for March, which is forecasted at 8.4%, a steep rise from 7.9% in February.

Benzinga

Microsoft Allegedly Exploited Its Influence To Gain Edge Over Amazon, Google, Alibaba: Bloomberg

Some Microsoft Corp (NASDAQ:MSFT) customers and rivals alleged that Microsoft repeatedly used its leverage over one market to hinder competition in another, Bloomberg reports. Microsoft’s practices cut across cloud computing, where it played catch-up, and productivity software, where it dominated. The Windows operating system held a 96% share of the personal-computer market in 2021,…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Entrepreneur Behind Microsoft's Wunderlist Raised $11M - Read Why

German entrepreneur Christian Reber who sold his to-do list app Wunderlist to Microsoft Corp (NASDAQ:MSFT) in 2015, raised funding for a follow-on app called Superlist, CNBC reports. Reber secured €10 million ($11 million) in a seed funding round led by venture capital firm EQT Ventures, reaching a total of €13.5 million. Superlist will…

Benzinga

China Starts Issuing Videogame Licenses Again: WSJ

China’s videogame regulator has started granting publishing licenses to new titles, ending a months-long freeze in the world’s largest mobile game market, the Wall Street Journal reported. The country stopped issuing licenses in July 2021, after Beijing tightened rules on the industry. The report noted approved 45 videogames last week, including…

Benzinga

Honda Motor Earmarks $64B Over 10 Years On EV Push, Firing Up Rivalry With Tesla

Honda Motor Co Ltd (NYSE:HMC) looks to spend ¥8 trillion ($64 billion) on research and development over the next decade, laying out an ambitious target to roll out 30 electric vehicle models globally by 2030. Honda's goals include producing 2 million EVs a year by 2030 to gain a share in the fast-growing…

Benzinga

Why Organigram Shares Are Trading Higher Today? Posts Record High Net Revenue In Q2, Still Among Top Canadian LPs

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of the cannabis company Organigram Inc, announced its results for the second quarter ended February 28, 2022.

Benzinga

Tesla Wrests SUV Leadership In China; Model Y Tops Category In Q1

Tesla, Inc. (NASDAQ: TSLA) has come out on top in China, one of its key markets.

Benzinga

Bosch Halts Production At Two China Plants: Reuters

German auto parts supplier Bosch has halted production in the Chinese cities of Shanghai and Changchun following COVID-19 curbs, Reuters reported. Bosch has closed shutters at a Thermotechnology factory in Shanghai and an automotive components site in Changchun in northeastern Jilin province. The report noted two other plants in Shanghai and Taicang city…

Benzinga

Ditch Apple, Google And Buy Shares In These Sectors Instead, Says Cramer

Investors should shun FAANG and Big Tech stocks such as Apple Inc (NASDAQ: AAPL) and Alphabet Inc (NASDAQ: GOOGL) (NASDAQ: GOOG) and turn to value

1 … 763 764 765 766

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.